Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Bhattacharyya, Swati ^a   Sargent, Jennifer L ^b   Du, Pan ^c   Lin, Simon ^c   Tourtellotte, Warren G ^a   Takehara, Kazuhiko ^d   Whitfield, Michael L ^b   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; TRANSCRIPTOME;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EGR 1 GENE; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMEDIATE EARLY GENE; LOCALIZED SCLERODERMA; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN FIBROBLAST; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; WOUND HEALING; ADENOVIRUS; ADULT; DNA MICROARRAY; FIBROBLAST; FIBROSIS; GENETICS; GENOMICS; METABOLISM; PATHOLOGY; REPRODUCIBILITY; SKIN;

ADENOVIRIDAE; ADULT; EARLY GROWTH RESPONSE PROTEIN 1; FIBROBLASTS; FIBROSIS; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 80052715015     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023082     Document Type: Article

References (26)

1. Jimenez SA, Derk CT, (2004) Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140: 37-45.
2. Rosenbloom J, Castro SV, Jimenez SA, (2010) Narrative review: fibrotic diseases Cellular and molecular mechanisms and novel therapies. Ann Intern Med 152: 159-166.
3. Varga J, Whitfield ML, (2009) Transforming growth factor-beta in systemic sclerosis (scleroderma). Front Biosci 1: 226-235.
4. Varga J, Pasche B, (2009) Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5: 200-206.
5. Thiel G, Cibelli G, (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287-292.
6. Chen SJ, Ning H, Ishida W, Sodin-Semrl S, Takagawa S, et al. (2006) The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J Biol Chem 281: 21183-21197.
7. Bhattacharyya S, Chen S-J, Wu M, Warner-Blankenship M, Ning H, et al. (2008) Smad-independent TGF-ß regulation of transcription factor Egr-1 and sustained expression in fibrosis: implications for scleroderma. Am J Pathol 173: 1085-1099.
8. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J, (2004) Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 50: 4008-4021.
9. Ehrengruber MU, Muhlebach SG, Sohrman S, Leutenegger CM, Lester HA, et al. (2000) Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene 258: 63-69.
10. Du P, Kibbe WA, Lin SM, (2007) nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays. Biol Direct 2007: 2-16.
11. Du P, Kibbe WA, Lin SM, (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
12. Lin SM, Du P, Huber W, Kibbe WA, (2008) Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 36: e11.
13. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 3: Article3.
14. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
15. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, et al. (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 16: e2696.
16. Fu M, Zhu X, Zhang J, Liang J, Lin Y, et al. (2003) Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 315: 33-41.
17. Varga J, Rosenbloom J, Jimenez SA, (1987) Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247: 597-604.
18. Sargent JL, Milano A, Bhattacharyya S, Varga J, Connolly MK, et al. (2009) TGFβ-responsive Gene Signature is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity. J Invest Dermatol 130: 694-705.
19. Khachigian LM, (2006) Early growth response-1 in cardiovascular pathobiology. Circ Res 98: 186-191.
20. Bhattacharyya S, Wu M, Fang F, Tourtellotte W, Feghali-Bostwick C, Varga J, (2011) Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy. Matrix Biol 30: 235-242.
21. Farivar AS, MacKinnon-Patterson B, Barnes AD, Mulligan MS, (2005) The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury. J Heart Lung Transplant 24: 2235-2242.
22. Farivar AS, Mackinnin-Patterson BC, Barnes AD, McCourtie AS, Mulligan MS, (2005) Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells. Ann Thorac Surg 79: 1010-1016.
23. Bea F, Blessing E, Shelley MI, Shultz JM, Rosenfeld ME, (2003) Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis 167: 187-194.
24. Bhattacharyya S, Ishida W, Wu M, Wilkes M, Mori Y, et al. (2009) A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene 28: 1285-1297.
25. Okada M, Wen F, Yan SF, (2002) Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J 16: 1861-1868.
26. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, et al. (2009) Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol 174: 519-533.